Drosophila melanogaster: A Model Organism to Study Cancer

Z Mirzoyan, M Sollazzo, M Allocca, AM Valenza… - Frontiers in …, 2019 - frontiersin.org
Cancer is a multistep disease driven by the activation of specific oncogenic pathways
concomitantly with the loss of function of tumor suppressor genes that act as sentinels to …

Animal models of Parkinson's disease: a source of novel treatments and clues to the cause of the disease

S Duty, P Jenner - British journal of pharmacology, 2011 - Wiley Online Library
Animal models of Parkinson's disease (PD) have proved highly effective in the discovery of
novel treatments for motor symptoms of PD and in the search for clues to the underlying …

Therapeutic potentials of plant iridoids in Alzheimer's and Parkinson's diseases: A review

B Dinda, M Dinda, G Kulsi, A Chakraborty… - European Journal of …, 2019 - Elsevier
Alzheimer's disease (AD) and Parkinson's disease (PD) are the most common age-related
neurodegenerative disorders, affecting several millions of aged people globally. Among …

Regulation of mitochondrial morphology and function by stearoylation of TFR1

D Senyilmaz, S Virtue, X Xu, CY Tan, JL Griffin… - Nature, 2015 - nature.com
Mitochondria are involved in a variety of cellular functions, including ATP production, amino
acid and lipid biogenesis and breakdown, signalling and apoptosis,,. Mitochondrial …

High‐throughput screening and small animal models, where are we?

J Giacomotto, L Ségalat - British journal of pharmacology, 2010 - Wiley Online Library
Current high‐throughput screening methods for drug discovery rely on the existence of
targets. Moreover, most of the hits generated during screenings turn out to be invalid after …

Rapamycin activation of 4E-BP prevents parkinsonian dopaminergic neuron loss

LS Tain, H Mortiboys, RN Tao, E Ziviani… - Nature …, 2009 - nature.com
Mutations in PINK1 and PARK2 cause autosomal recessive parkinsonism, a
neurodegenerative disorder that is characterized by the loss of dopaminergic neurons. To …

[HTML][HTML] Mitochondrial dysfunction in the limelight of Parkinson's disease pathogenesis

R Banerjee, AA Starkov, MF Beal, B Thomas - Biochimica et Biophysica …, 2009 - Elsevier
Parkinson's disease (PD) is a progressive neurodegenerative movement disorder with
unknown etiology. It is marked by widespread neurodegeneration in the brain with profound …

Neuroinflammation: An overview of neurodegenerative and metabolic diseases and of biotechnological studies

AP de Araújo Boleti, TM de Oliveira Flores… - Neurochemistry …, 2020 - Elsevier
Neuroinflammation is an important factor contributing to cognitive impairment and
neurodegenerative diseases, including Alzheimer's disease (AD), Parkinson's disease (PD) …

Drosophila in the study of neurodegenerative disease

JL Marsh, LM Thompson - Neuron, 2006 - cell.com
As populations benefit from increasing lifespans, neurodegenerative diseases have
emerged as a critical health concern. How can the fruit fly, Drosophila melanogaster …

Autophagy-lysosomal pathway as potential therapeutic target in Parkinson's disease

SR Bonam, C Tranchant, S Muller - Cells, 2021 - mdpi.com
Cellular quality control systems have gained much attention in recent decades. Among
these, autophagy is a natural self-preservation mechanism that continuously eliminates toxic …